Search Results
Found 1 results
510(k) Data Aggregation
(150 days)
IMMUNETECH TOTAL IGE SYSTEM
The ImmuneTech™ Total IgE System is a quantitative in vitro diagnostic test system that measures total IgE in human serum. The ImmuneTech™ Total IgE System is intended for clinical laboratory use. The ImmuneTech™ Total IgE System may only be run on the Luminex 100TM Integrated System.
The ImmuneTech™ Total IgE System is a quantitative in vitro diagnostic test system used as an aid in the clinical diagnosis of IgE mediated allergic disorders.
ImmuneTech™ Total IgE System is a test for the measurement of total IgE in human serum. The ImmuneTech™ Total IgE System consists of two components.
-
- Flow Cytometer instrument with software for ImmuneTech™ Total IgE System
-
- ImmuneTech™ Total IgE System Reagents
A serum sample is mixed with anti-IgE coupled microspheres. If present, IgE in the sample will bind with the microspheres and form an anti-human IgE / IgE complex. This complex is then sequentially incubated with biotin-labeled-anti-human IgE antibody and fluorescent-labeled-streptavidin. If IgE is present in the sample, the final sandwich complex of anti-human IgE / IgE / biotin-anti IgE / fluorescent-streptavidin will form. Measurement of the fluorescent signal from the sandwich complex is directly proportional to the concentration of total IgE in the sample. The flow cytometer with ImmuneTech ™ Total IgE System specific software will measure total IgE concentrations.
This summarizes the acceptance criteria and study details for the ImmuneTech™ Total IgE System, based on the provided 510(k) summary.
I. Acceptance Criteria and Reported Device Performance
Performance Metric | Acceptance Criteria (Implied) | Reported Device Performance (ImmuneTech™ Total IgE System) |
---|---|---|
Method Comparison | High correlation to predicate | Correlation Coefficient 0.97; y=1.00x+6.03 |
Sensitivity | Low detection limit | 2 IU/mL |
Specificity | No cross-reactivity | Non cross reactive to IgG, IgA or IgM |
Recovery | High recovery rate | 99.8% |
Between Day Precision (CV) | Low variability | 3-10% |
Within Day Precision (CV) | Low variability | 2-9% |
II. Study Details
-
Sample size used for the test set and the data provenance:
- The document does not explicitly state the specific sample size for the test set.
- The data provenance is not specified (e.g., country of origin, retrospective or prospective).
-
Number of experts used to establish the ground truth for the test set and the qualifications of those experts:
- Not applicable. The ground truth for this in vitro diagnostic device is based on analytical performance metrics (e.g., comparison to a predicate device, known concentrations for sensitivity, specificity, and recovery).
-
Adjudication method for the test set:
- Not applicable. This is an in vitro diagnostic device assessing analytical performance, not a diagnostic imaging or clinical judgment study requiring expert adjudication.
-
If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
- No. This is an in vitro diagnostic system, not a device that involves human readers or AI assistance in interpretation in the context of an MRMC study.
-
If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:
- Yes, at least in part. The studies evaluating "Method Comparison, Sensitivity, Specificity, Accuracy (recovery) and Precision" describe the analytical performance of the ImmuneTech™ Total IgE System itself, independent of human interpretation. While the system operates on a flow cytometer, the reported performance metrics focus on the device's ability to measure IgE concentrations directly.
-
The type of ground truth used:
- The ground truth appears to be established through:
- Comparison to a legally marketed predicate device: "MyAllergyTest™ System" and "Pharmacia CAP System IgE FEIA" were used as comparators for method comparison.
- Known concentrations/samples: For sensitivity, specificity, recovery, and precision studies, it is implied that samples with known IgE concentrations or characteristics (e.g., non-atopic vs. atopic individuals, samples without cross-reacting substances) were used.
- The ground truth appears to be established through:
-
The sample size for the training set:
- Not specified. The document does not mention details about a training set, as this typically applies more to machine learning algorithms, which are not explicitly detailed here beyond the software component. The performance data focuses on analytical validation.
-
How the ground truth for the training set was established:
- Not applicable, as a training set and its ground truth establishment are not discussed in the provided summary.
Ask a specific question about this device
Page 1 of 1